US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CINGULATE INC.

6.49

-0.3200-4.70%

Post-market: 6.600.1100+1.69%17:49 EST

Volume:390.69K

Turnover:2.60M

Market Cap:48.33M

PE:-1.27

High:6.88

Open:6.84

Low:6.43

Close:6.81

52wk High:7.92

52wk Low:3.20

Shares:7.45M

Float Shares:7.44M

Volume Ratio:1.26

T/O Rate:5.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.1005

EPS(LYR):-10.1953

ROE:-275.85%

ROA:-106.65%

PB:13.91

PE(LYR):-0.64

Loading ...

Overview Company News Filings

Cingulate price target lowered to $16 from $17 at Roth Capital

Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences

Calendar of U.S. Earnings Expected in the Week Ahead

Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment

Calendar of U.S. Earnings Expected in the Week Ahead

Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year

Biopharma firm Cingulate's Q3 net loss widens, misses analyst expectations

Cingulate Inc. posts third quarter loss of $6.0 million

Cingulate Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Bryan Wade Downey

Cingulate Inc. Appoints Bryan Downey as Chief Commercial Officer

Press Release: Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

BRIEF-Cingulate Presents Positive Phase 3 Results for CTx-1301

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

Cingulate Is Maintained at Buy by Roth Capital

Strategic Advancements and Partnerships Propel Cingulate Inc. Towards Market Success

Cingulate price target raised to $17 from $10 at Roth Capital

FDA Accepts Cingulate’s New Drug Application for Ctx-1301 in Attention-Deficit/Hyperactivity Disorder (Adhd) and Sets a May 31, 2026 Pdufa Date

THOMSON REUTERS

FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date

Cingulate Inc Approves Stock Issuance Proposal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CING/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CING","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CING\",,,,,undefined,":{"symbol":"CING","market":"US","secType":"STK","nameCN":"CINGULATE INC.","latestPrice":6.49,"timestamp":1772139600000,"preClose":6.81,"halted":0,"volume":390693,"hourTrading":{"tag":"盘后","latestPrice":6.6,"preClose":6.49,"latestTime":"17:49 EST","volume":1652,"amount":10834.6101164,"timestamp":1772146190372,"change":0.11,"changeRate":0.016949,"amplitude":0.035562},"delay":0,"changeRate":-0.046989720998531485,"floatShares":7438400,"shares":7446300,"eps":-5.100541,"marketStatus":"Post-Mkt","change":-0.32,"latestTime":"02-26 18:33:56 EST","open":6.84,"high":6.88,"low":6.43,"amount":2598792.9441360002,"amplitude":0.066079,"askPrice":7,"askSize":20,"bidPrice":6.45,"bidSize":1349,"shortable":3,"etf":0,"ttmEps":-5.100541,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"listingDate":1633579200000,"exchange":"NASDAQ","adjPreClose":6.81,"preHourTrading":{"tag":"盘前","latestPrice":6.78,"preClose":6.81,"latestTime":"09:28 EST","volume":11583,"amount":79093.1765052,"timestamp":1772116096157,"change":-0.03,"changeRate":-0.004405,"amplitude":0.045521},"postHourTrading":{"tag":"盘后","latestPrice":6.6,"preClose":6.49,"latestTime":"17:49 EST","volume":1652,"amount":10834.6101164,"timestamp":1772146190372,"change":0.11,"changeRate":0.016949,"amplitude":0.035562},"volumeRatio":1.264459},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CING\",,,,,undefined,":{"symbol":"CING","floatShares":7438400,"roa":"-106.65%","roe":"-275.85%","lyrEps":-10.195283,"volumeRatio":1.264459,"shares":7446300,"dividePrice":0,"high":6.88,"amplitude":0.066079,"preClose":6.81,"low":6.43,"week52Low":3.2,"pbRate":"13.91","week52High":7.92,"institutionHeld":0,"latestPrice":6.49,"committee":0.970782,"eps":-5.100541,"divideRate":0,"volume":390693,"delay":0,"ttmEps":-5.100541,"open":6.84,"prevYearClose":4.34,"prevWeekClose":5.89,"prevMonthClose":5.74,"prevQuarterClose":4.34,"fiveDayClose":6.05,"twentyDayClose":5.91,"sixtyDayClose":3.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CING\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-09","symbol":"CING","defaultRemindTime":1723210200000,"type":"split","dateTimestamp":1723176000000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2023-11-30","symbol":"CING","defaultRemindTime":1701354600000,"type":"split","dateTimestamp":1701320400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CING\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CING\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1745470800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CING\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CING","date":"2026-02-25","current":-1.335152,"percent":0.007767,"low":-33.556234,"twenty":-1.11626,"median":-0.704174,"eighty":-0.450055,"high":-0.074542,"avg":-0.959593,"sd":2.317822,"marketCap":66053074},"quantilePoints":[{"date":"2021-10-08","current":-33.556234,"twenty":-33.556234,"median":-33.556234,"eighty":-33.556234,"marketCap":171162464},{"date":"2021-10-15","current":-27.455101,"twenty":-33.556234,"median":-30.505668,"eighty":-27.455101,"marketCap":140042016},{"date":"2021-12-10","current":-2.162019,"twenty":-33.556234,"median":-27.455101,"eighty":-2.614398,"marketCap":41618636},{"date":"2021-12-17","current":-1.521639,"twenty":-27.455101,"median":-3.069714,"eighty":-1.815391,"marketCap":29291377},{"date":"2021-12-23","current":-1.498138,"twenty":-27.455101,"median":-2.223707,"eighty":-1.598014,"marketCap":28839000},{"date":"2021-12-31","current":-1.621514,"twenty":-27.455101,"median":-1.815391,"eighty":-1.551014,"marketCap":31213977},{"date":"2022-01-07","current":-1.445263,"twenty":-8.311045,"median":-1.680265,"eighty":-1.516939,"marketCap":27821153},{"date":"2022-01-14","current":-1.527514,"twenty":-3.525031,"median":-1.618166,"eighty":-1.496963,"marketCap":29404471},{"date":"2022-01-21","current":-1.374762,"twenty":-2.978651,"median":-1.568639,"eighty":-1.487563,"marketCap":26464024},{"date":"2022-01-28","current":-1.051634,"twenty":-2.416996,"median":-1.556889,"eighty":-1.445263,"marketCap":20243847},{"date":"2022-02-04","current":-1.075135,"twenty":-2.211369,"median":-1.527514,"eighty":-1.297212,"marketCap":20696223},{"date":"2022-02-11","current":-0.887133,"twenty":-1.978718,"median":-1.521639,"eighty":-1.105685,"marketCap":17077212},{"date":"2022-02-18","current":-0.851883,"twenty":-1.831841,"median":-1.498138,"eighty":-1.065735,"marketCap":16398647},{"date":"2022-02-25","current":-0.810757,"twenty":-1.794241,"median":-1.480513,"eighty":-1.001109,"marketCap":15606988},{"date":"2022-03-04","current":-0.752007,"twenty":-1.741366,"median":-1.451138,"eighty":-0.873033,"marketCap":14476047},{"date":"2022-03-11","current":-0.649841,"twenty":-1.68614,"median":-1.43645,"eighty":-0.848358,"marketCap":13458200},{"date":"2022-03-18","current":-1.010257,"twenty":-1.63914,"median":-1.280762,"eighty":-0.822507,"marketCap":20922412},{"date":"2022-03-25","current":-1.163161,"twenty":-1.620175,"median":-1.141317,"eighty":-0.842482,"marketCap":24089047},{"date":"2022-04-01","current":-1.010257,"twenty":-1.617155,"median":-1.117867,"eighty":-0.848358,"marketCap":20922412},{"date":"2022-04-08","current":-1.015718,"twenty":-1.596839,"median":-1.098635,"eighty":-0.851883,"marketCap":21035506},{"date":"2022-04-14","current":-0.96657,"twenty":-1.567464,"median":-1.086885,"eighty":-0.853058,"marketCap":20017659},{"date":"2022-04-22","current":-0.906501,"twenty":-1.561589,"median":-1.075135,"eighty":-0.858933,"marketCap":18773623},{"date":"2022-04-29","current":-0.884657,"twenty":-1.556889,"median":-1.05935,"eighty":-0.858933,"marketCap":18321247},{"date":"2022-05-06","current":-0.764519,"twenty":-1.552189,"median":-1.045759,"eighty":-0.847183,"marketCap":15833176},{"date":"2022-05-13","current":-0.579861,"twenty":-1.532214,"median":-1.026639,"eighty":-0.798804,"marketCap":14136765},{"date":"2022-05-20","current":-0.552028,"twenty":-1.527514,"median":-1.015718,"eighty":-0.780997,"marketCap":13458200},{"date":"2022-05-27","current":-0.524194,"twenty":-1.526339,"median":-1.010257,"eighty":-0.764519,"marketCap":12779635},{"date":"2022-06-03","current":-0.613493,"twenty":-1.521639,"median":-1.010257,"eighty":-0.742675,"marketCap":14956697},{"date":"2022-06-10","current":-0.649444,"twenty":-1.521639,"median":-0.980222,"eighty":-0.705006,"marketCap":15833176},{"date":"2022-06-17","current":-0.672639,"twenty":-1.515763,"median":-0.972031,"eighty":-0.649841,"marketCap":16398647},{"date":"2022-06-24","current":-0.677278,"twenty":-1.501663,"median":-0.957634,"eighty":-0.649841,"marketCap":16511741},{"date":"2022-07-01","current":-0.686555,"twenty":-1.493438,"median":-0.937113,"eighty":-0.651379,"marketCap":16737929},{"date":"2022-07-08","current":-0.742222,"twenty":-1.485213,"median":-0.925613,"eighty":-0.655939,"marketCap":18095059},{"date":"2022-07-15","current":-0.728305,"twenty":-1.473463,"median":-0.90104,"eighty":-0.661505,"marketCap":17755776},{"date":"2022-07-22","current":-0.654083,"twenty":-1.461713,"median":-0.881927,"eighty":-0.656866,"marketCap":15946270},{"date":"2022-07-29","current":-0.570583,"twenty":-1.449963,"median":-0.863633,"eighty":-0.649682,"marketCap":13910576},{"date":"2022-08-05","current":-0.79325,"twenty":-1.445263,"median":-0.851887,"eighty":-0.649444,"marketCap":19339094},{"date":"2022-08-12","current":-0.691445,"twenty":-1.439975,"median":-0.846008,"eighty":-0.649444,"marketCap":18660529},{"date":"2022-08-19","current":-0.624396,"twenty":-1.399437,"median":-0.811281,"eighty":-0.634786,"marketCap":16851023},{"date":"2022-08-26","current":-0.72916,"twenty":-1.367712,"median":-0.797284,"eighty":-0.634786,"marketCap":19678376},{"date":"2022-09-02","current":-0.641158,"twenty":-1.264311,"median":-0.793132,"eighty":-0.639667,"marketCap":17303400},{"date":"2022-09-09","current":-0.649539,"twenty":-1.184371,"median":-0.781141,"eighty":-0.637748,"marketCap":17529588},{"date":"2022-09-16","current":-0.540584,"twenty":-1.154423,"median":-0.775507,"eighty":-0.631938,"marketCap":14589141},{"date":"2022-09-23","current":-0.419058,"twenty":-1.140694,"median":-0.764968,"eighty":-0.624396,"marketCap":11309412},{"date":"2022-09-30","current":-0.448392,"twenty":-1.131646,"median":-0.763757,"eighty":-0.619727,"marketCap":12101070},{"date":"2022-10-07","current":-0.519631,"twenty":-1.118188,"median":-0.756392,"eighty":-0.611749,"marketCap":14023670},{"date":"2022-10-14","current":-0.460963,"twenty":-1.11391,"median":-0.742675,"eighty":-0.5845,"marketCap":12440353},{"date":"2022-10-21","current":-0.469344,"twenty":-1.105685,"median":-0.734823,"eighty":-0.575222,"marketCap":12666541},{"date":"2022-10-28","current":-0.448392,"twenty":-1.098233,"median":-0.72916,"eighty":-0.571993,"marketCap":12101070},{"date":"2022-11-04","current":-0.441687,"twenty":-1.093333,"median":-0.725985,"eighty":-0.563161,"marketCap":11920120},{"date":"2022-11-11","current":-0.44001,"twenty":-1.082446,"median":-0.719028,"eighty":-0.549245,"marketCap":11874882},{"date":"2022-11-18","current":-0.632898,"twenty":-1.075526,"median":-0.714728,"eighty":-0.552479,"marketCap":9952282},{"date":"2022-11-25","current":-0.647282,"twenty":-1.075135,"median":-0.707458,"eighty":-0.552254,"marketCap":10178470},{"date":"2022-12-02","current":-0.695901,"twenty":-1.074173,"median":-0.705006,"eighty":-0.553858,"marketCap":10942987},{"date":"2022-12-09","current":-0.69795,"twenty":-1.068131,"median":-0.700056,"eighty":-0.557594,"marketCap":10975218},{"date":"2022-12-16","current":-0.740779,"twenty":-1.057807,"median":-0.69964,"eighty":-0.562233,"marketCap":11648694},{"date":"2022-12-23","current":-0.687198,"twenty":-1.051634,"median":-0.697627,"eighty":-0.565953,"marketCap":10806143},{"date":"2022-12-30","current":-0.719203,"twenty":-1.051634,"median":-0.697627,"eighty":-0.565991,"marketCap":11309412},{"date":"2023-01-06","current":-0.762355,"twenty":-1.042234,"median":-0.698795,"eighty":-0.569665,"marketCap":11987976},{"date":"2023-01-13","current":-0.706832,"twenty":-1.033657,"median":-0.697627,"eighty":-0.570583,"marketCap":11114890},{"date":"2023-01-20","current":-0.701223,"twenty":-1.028823,"median":-0.697627,"eighty":-0.572699,"marketCap":11026676},{"date":"2023-01-27","current":-0.683602,"twenty":-1.023363,"median":-0.697788,"eighty":-0.574109,"marketCap":10749596},{"date":"2023-02-03","current":-0.712011,"twenty":-1.017902,"median":-0.69795,"eighty":-0.574777,"marketCap":11196317},{"date":"2023-02-10","current":-0.704675,"twenty":-1.015718,"median":-0.700056,"eighty":-0.575222,"marketCap":11080961},{"date":"2023-02-17","current":-0.791123,"twenty":-1.012441,"median":-0.704675,"eighty":-0.575222,"marketCap":12440353},{"date":"2023-02-24","current":-1.121956,"twenty":-1.013534,"median":-0.705006,"eighty":-0.577078,"marketCap":17642682},{"date":"2023-03-03","current":-0.970924,"twenty":-1.024455,"median":-0.710169,"eighty":-0.580913,"marketCap":15267706},{"date":"2023-03-10","current":-1.183647,"twenty":-1.04166,"median":-0.712011,"eighty":-0.583294,"marketCap":20922412},{"date":"2023-03-17","current":-0.592015,"twenty":-1.03677,"median":-0.711183,"eighty":-0.5845,"marketCap":10464598},{"date":"2023-03-24","current":-0.659003,"twenty":-1.029916,"median":-0.706832,"eighty":-0.58398,"marketCap":11648694},{"date":"2023-03-31","current":-0.630212,"twenty":-1.024455,"median":-0.704675,"eighty":-0.5845,"marketCap":11139770},{"date":"2023-04-06","current":-0.620679,"twenty":-1.020087,"median":-0.700848,"eighty":-0.584736,"marketCap":10971260},{"date":"2023-04-14","current":-0.652605,"twenty":-1.015718,"median":-0.69795,"eighty":-0.586373,"marketCap":11535600},{"date":"2023-04-21","current":-0.652605,"twenty":-1.01539,"median":-0.697627,"eighty":-0.589714,"marketCap":11535600},{"date":"2023-04-28","current":-0.684596,"twenty":-1.013312,"median":-0.697627,"eighty":-0.593286,"marketCap":12101070},{"date":"2023-05-05","current":-0.697392,"twenty":-1.010257,"median":-0.697627,"eighty":-0.600272,"marketCap":12327259},{"date":"2023-05-12","current":-0.705244,"twenty":-1.010257,"median":-0.697627,"eighty":-0.608577,"marketCap":11761788},{"date":"2023-05-19","current":-0.679181,"twenty":-1.010257,"median":-0.697627,"eighty":-0.611554,"marketCap":11327111},{"date":"2023-05-26","current":-0.617503,"twenty":-1.008073,"median":-0.696624,"eighty":-0.612565,"marketCap":10298474},{"date":"2023-06-02","current":-0.637364,"twenty":-0.999335,"median":-0.695635,"eighty":-0.613493,"marketCap":10629701},{"date":"2023-06-09","current":-0.682138,"twenty":-0.986229,"median":-0.695635,"eighty":-0.615044,"marketCap":11376426},{"date":"2023-06-16","current":-0.687752,"twenty":-0.978584,"median":-0.695768,"eighty":-0.615898,"marketCap":11470059},{"date":"2023-06-23","current":-0.631609,"twenty":-0.976599,"median":-0.694193,"eighty":-0.615665,"marketCap":10533727},{"date":"2023-06-30","current":-0.645645,"twenty":-0.974613,"median":-0.691445,"eighty":-0.616313,"marketCap":10767810},{"date":"2023-07-07","current":-0.617573,"twenty":-0.972031,"median":-0.69125,"eighty":-0.617503,"marketCap":10299644},{"date":"2023-07-14","current":-0.575466,"twenty":-0.970924,"median":-0.690966,"eighty":-0.615432,"marketCap":9597396},{"date":"2023-07-21","current":-0.542342,"twenty":-0.96657,"median":-0.690435,"eighty":-0.607882,"marketCap":9044960},{"date":"2023-07-28","current":-0.469799,"twenty":-0.957634,"median":-0.687858,"eighty":-0.589139,"marketCap":7835124},{"date":"2023-08-04","current":-0.465402,"twenty":-0.956045,"median":-0.687503,"eighty":-0.5845,"marketCap":7761795},{"date":"2023-08-11","current":-0.454991,"twenty":-0.947836,"median":-0.687198,"eighty":-0.581753,"marketCap":7588158},{"date":"2023-08-18","current":-0.519697,"twenty":-0.931852,"median":-0.686451,"eighty":-0.575222,"marketCap":10005971},{"date":"2023-08-25","current":-0.534418,"twenty":-0.928344,"median":-0.684243,"eighty":-0.570583,"marketCap":10289396},{"date":"2023-09-01","current":-0.522218,"twenty":-0.923975,"median":-0.683423,"eighty":-0.561349,"marketCap":10054514},{"date":"2023-09-08","current":-0.447395,"twenty":-0.913054,"median":-0.683243,"eighty":-0.55391,"marketCap":8613904},{"date":"2023-09-15","current":-0.589599,"twenty":-0.904317,"median":-0.681822,"eighty":-0.550587,"marketCap":11351830},{"date":"2023-09-22","current":-0.686,"twenty":-0.902132,"median":-0.681822,"eighty":-0.551548,"marketCap":13207886},{"date":"2023-09-28","current":-0.613609,"twenty":-0.892696,"median":-0.681089,"eighty":-0.552705,"marketCap":11814106},{"date":"2023-10-05","current":-0.58653,"twenty":-0.886638,"median":-0.680006,"eighty":-0.553407,"marketCap":11292742},{"date":"2023-10-13","current":-0.487421,"twenty":-0.884621,"median":-0.67823,"eighty":-0.550106,"marketCap":9384550},{"date":"2023-10-20","current":-0.413586,"twenty":-0.883419,"median":-0.677278,"eighty":-0.544811,"marketCap":7962965},{"date":"2023-10-27","current":-0.389937,"twenty":-0.881308,"median":-0.677278,"eighty":-0.544129,"marketCap":7507640},{"date":"2023-11-03","current":-0.374501,"twenty":-0.872644,"median":-0.674345,"eighty":-0.540557,"marketCap":7210445},{"date":"2023-11-10","current":-0.360133,"twenty":-0.86549,"median":-0.672109,"eighty":-0.536153,"marketCap":6933802},{"date":"2023-11-17","current":-0.257169,"twenty":-0.863236,"median":-0.668858,"eighty":-0.53123,"marketCap":5453341},{"date":"2023-11-24","current":-0.31585,"twenty":-0.860886,"median":-0.668429,"eighty":-0.524194,"marketCap":6697678},{"date":"2023-12-01","current":-0.277053,"twenty":-0.855412,"median":-0.665401,"eighty":-0.521193,"marketCap":5874990},{"date":"2023-12-08","current":-0.164818,"twenty":-0.851888,"median":-0.665401,"eighty":-0.519446,"marketCap":3495010},{"date":"2023-12-15","current":-0.127701,"twenty":-0.851883,"median":-0.664615,"eighty":-0.511644,"marketCap":2707930},{"date":"2023-12-22","current":-0.090584,"twenty":-0.849533,"median":-0.663089,"eighty":-0.50742,"marketCap":1920850},{"date":"2023-12-29","current":-0.433917,"twenty":-0.846008,"median":-0.659003,"eighty":-0.505223,"marketCap":9201340},{"date":"2024-01-05","current":-0.317705,"twenty":-0.845132,"median":-0.659003,"eighty":-0.499675,"marketCap":6737030},{"date":"2024-01-12","current":-0.468453,"twenty":-0.841898,"median":-0.657279,"eighty":-0.496427,"marketCap":9933671},{"date":"2024-01-19","current":-0.365188,"twenty":-0.83776,"median":-0.65373,"eighty":-0.485067,"marketCap":7743913},{"date":"2024-01-26","current":-0.269446,"twenty":-0.825244,"median":-0.652634,"eighty":-0.473931,"marketCap":5713673},{"date":"2024-02-02","current":-0.229781,"twenty":-0.811386,"median":-0.652605,"eighty":-0.469354,"marketCap":4872574},{"date":"2024-02-09","current":-0.085484,"twenty":-0.808407,"median":-0.652445,"eighty":-0.466657,"marketCap":1812713},{"date":"2024-02-16","current":-0.217565,"twenty":-0.802255,"median":-0.651022,"eighty":-0.462556,"marketCap":4613518},{"date":"2024-02-23","current":-0.208187,"twenty":-0.798109,"median":-0.649895,"eighty":-0.460342,"marketCap":4414659},{"date":"2024-03-01","current":-0.306956,"twenty":-0.796477,"median":-0.64969,"eighty":-0.453064,"marketCap":6509088},{"date":"2024-03-08","current":-0.271582,"twenty":-0.793226,"median":-0.649539,"eighty":-0.449163,"marketCap":5758970},{"date":"2024-03-15","current":-0.273864,"twenty":-0.793132,"median":-0.649444,"eighty":-0.448392,"marketCap":5807365},{"date":"2024-03-22","current":-0.246478,"twenty":-0.79273,"median":-0.649154,"eighty":-0.447462,"marketCap":5226628},{"date":"2024-03-28","current":-0.24876,"twenty":-0.791123,"median":-0.647282,"eighty":-0.444201,"marketCap":5275023},{"date":"2024-04-05","current":-0.227798,"twenty":-0.781382,"median":-0.646574,"eighty":-0.44001,"marketCap":5361203},{"date":"2024-04-12","current":-0.204713,"twenty":-0.780901,"median":-0.645645,"eighty":-0.433575,"marketCap":4817918},{"date":"2024-04-19","current":-0.187348,"twenty":-0.780901,"median":-0.640128,"eighty":-0.42742,"marketCap":4409214},{"date":"2024-04-26","current":-0.215809,"twenty":-0.776739,"median":-0.639809,"eighty":-0.413586,"marketCap":5079042},{"date":"2024-05-03","current":-0.287745,"twenty":-0.776739,"median":-0.639489,"eighty":-0.388132,"marketCap":6772056},{"date":"2024-05-10","current":-0.237801,"twenty":-0.776739,"median":-0.638627,"eighty":-0.374501,"marketCap":5351133},{"date":"2024-05-17","current":-0.212275,"twenty":-0.775507,"median":-0.637095,"eighty":-0.361053,"marketCap":4776718},{"date":"2024-05-24","current":-0.221679,"twenty":-0.766875,"median":-0.635118,"eighty":-0.343,"marketCap":4988345},{"date":"2024-05-31","current":-0.207125,"twenty":-0.765708,"median":-0.632898,"eighty":-0.314502,"marketCap":4660839},{"date":"2024-06-07","current":-0.207356,"twenty":-0.764698,"median":-0.631609,"eighty":-0.3051,"marketCap":4666038},{"date":"2024-06-14","current":-0.212765,"twenty":-0.764519,"median":-0.630212,"eighty":-0.297266,"marketCap":4787761},{"date":"2024-06-21","current":-0.19035,"twenty":-0.764214,"median":-0.628292,"eighty":-0.287229,"marketCap":4283350},{"date":"2024-06-28","current":-0.179326,"twenty":-0.763909,"median":-0.627537,"eighty":-0.282537,"marketCap":4035290},{"date":"2024-07-05","current":-0.108669,"twenty":-0.763114,"median":-0.626298,"eighty":-0.279209,"marketCap":2445325},{"date":"2024-07-12","current":-0.163139,"twenty":-0.762487,"median":-0.624712,"eighty":-0.273922,"marketCap":3671045},{"date":"2024-07-15","current":-0.179035,"twenty":-0.762421,"median":-0.624667,"eighty":-0.273864,"marketCap":4028731},{"date":"2024-08-02","current":-0.155299,"twenty":-0.762355,"median":-0.624621,"eighty":-0.273864,"marketCap":3494630},{"date":"2024-08-09","current":-0.10968,"twenty":-0.762355,"median":-0.624396,"eighty":-0.2693,"marketCap":2468069},{"date":"2024-08-16","current":-0.219061,"twenty":-0.762355,"median":-0.622537,"eighty":-0.265123,"marketCap":4183166},{"date":"2024-08-23","current":-0.564453,"twenty":-0.762355,"median":-0.623466,"eighty":-0.265211,"marketCap":10778738},{"date":"2024-08-30","current":-0.582332,"twenty":-0.760777,"median":-0.620679,"eighty":-0.265211,"marketCap":11120164},{"date":"2024-09-06","current":-0.68717,"twenty":-0.762355,"median":-0.624396,"eighty":-0.266796,"marketCap":13122125},{"date":"2024-09-13","current":-0.678038,"twenty":-0.762355,"median":-0.624396,"eighty":-0.268878,"marketCap":12947744},{"date":"2024-09-20","current":-0.58672,"twenty":-0.761093,"median":-0.622537,"eighty":-0.269417,"marketCap":11203940},{"date":"2024-09-27","current":-0.58672,"twenty":-0.7585,"median":-0.619266,"eighty":-0.270229,"marketCap":11203940},{"date":"2024-10-04","current":-0.550192,"twenty":-0.753192,"median":-0.617503,"eighty":-0.271351,"marketCap":10506419},{"date":"2024-10-11","current":-0.709395,"twenty":-0.747173,"median":-0.61695,"eighty":-0.273408,"marketCap":13546534},{"date":"2024-10-18","current":-0.715771,"twenty":-0.747173,"median":-0.617853,"eighty":-0.273864,"marketCap":13668300},{"date":"2024-10-25","current":-0.738089,"twenty":-0.753192,"median":-0.622321,"eighty":-0.273941,"marketCap":14094483},{"date":"2024-10-31","current":-0.679106,"twenty":-0.748381,"median":-0.624396,"eighty":-0.27396,"marketCap":12968142},{"date":"2024-11-08","current":-0.640545,"twenty":-0.745065,"median":-0.622537,"eighty":-0.275816,"marketCap":10471927},{"date":"2024-11-15","current":-0.829168,"twenty":-0.759069,"median":-0.624396,"eighty":-0.277901,"marketCap":13555623},{"date":"2024-11-22","current":-0.913657,"twenty":-0.762487,"median":-0.624621,"eighty":-0.279209,"marketCap":14936883},{"date":"2024-11-29","current":-0.856676,"twenty":-0.764519,"median":-0.625706,"eighty":-0.280107,"marketCap":14005335},{"date":"2024-12-06","current":-0.817379,"twenty":-0.76969,"median":-0.626508,"eighty":-0.280711,"marketCap":13362889},{"date":"2024-12-13","current":-0.829168,"twenty":-0.776739,"median":-0.627998,"eighty":-0.281624,"marketCap":13555623},{"date":"2024-12-20","current":-0.80559,"twenty":-0.78119,"median":-0.630212,"eighty":-0.28455,"marketCap":13170155},{"date":"2024-12-27","current":-0.94706,"twenty":-0.790873,"median":-0.631609,"eighty":-0.287057,"marketCap":15482963},{"date":"2025-01-03","current":-1.002076,"twenty":-0.793132,"median":-0.632898,"eighty":-0.287745,"marketCap":16382388},{"date":"2025-01-10","current":-0.846852,"twenty":-0.798459,"median":-0.634232,"eighty":-0.291564,"marketCap":13844724},{"date":"2025-01-17","current":-0.978497,"twenty":-0.80559,"median":-0.636967,"eighty":-0.296053,"marketCap":15996920},{"date":"2025-01-24","current":-1.002076,"twenty":-0.806286,"median":-0.637223,"eighty":-0.297266,"marketCap":16382388},{"date":"2025-01-31","current":-0.894009,"twenty":-0.818165,"median":-0.638773,"eighty":-0.300285,"marketCap":14615660},{"date":"2025-02-07","current":-0.943186,"twenty":-0.828084,"median":-0.639809,"eighty":-0.302205,"marketCap":15419630},{"date":"2025-02-14","current":-0.876537,"twenty":-0.836575,"median":-0.639887,"eighty":-0.304385,"marketCap":14330020},{"date":"2025-02-21","current":-0.85432,"twenty":-0.841371,"median":-0.640128,"eighty":-0.306168,"marketCap":13966817},{"date":"2025-02-28","current":-0.852301,"twenty":-0.844751,"median":-0.641158,"eighty":-0.306801,"marketCap":13933798},{"date":"2025-03-07","current":-0.773533,"twenty":-0.844418,"median":-0.645889,"eighty":-0.307818,"marketCap":12646077},{"date":"2025-03-14","current":-0.73314,"twenty":-0.843192,"median":-0.646941,"eighty":-0.311806,"marketCap":11985708},{"date":"2025-03-21","current":-0.826045,"twenty":-0.841371,"median":-0.648137,"eighty":-0.31585,"marketCap":13504558},{"date":"2025-03-28","current":-0.923921,"twenty":-0.841371,"median":-0.649154,"eighty":-0.316592,"marketCap":14363038},{"date":"2025-04-04","current":-0.996294,"twenty":-0.84556,"median":-0.649444,"eighty":-0.327823,"marketCap":15488124},{"date":"2025-04-11","current":-0.887211,"twenty":-0.850782,"median":-0.649539,"eighty":-0.347439,"marketCap":13792344},{"date":"2025-04-17","current":-1.013262,"twenty":-0.85189,"median":-0.649841,"eighty":-0.354862,"marketCap":15751912},{"date":"2025-04-25","current":-1.052048,"twenty":-0.856205,"median":-0.649895,"eighty":-0.358359,"marketCap":16354856},{"date":"2025-05-02","current":-1.042351,"twenty":-0.861471,"median":-0.651764,"eighty":-0.360317,"marketCap":16204120},{"date":"2025-05-09","current":-0.991446,"twenty":-0.867504,"median":-0.652605,"eighty":-0.36188,"marketCap":15412756},{"date":"2025-05-16","current":-0.889406,"twenty":-0.878665,"median":-0.652605,"eighty":-0.366166,"marketCap":14564866},{"date":"2025-05-23","current":-0.812316,"twenty":-0.878591,"median":-0.652663,"eighty":-0.370079,"marketCap":13302452},{"date":"2025-05-30","current":-0.918171,"twenty":-0.879197,"median":-0.653906,"eighty":-0.370079,"marketCap":15035916},{"date":"2025-06-06","current":-1.10058,"twenty":-0.884657,"median":-0.658722,"eighty":-0.374501,"marketCap":18023051},{"date":"2025-06-13","current":-1.140767,"twenty":-0.892059,"median":-0.659003,"eighty":-0.37613,"marketCap":18681137},{"date":"2025-06-20","current":-1.15373,"twenty":-0.900709,"median":-0.663089,"eighty":-0.376705,"marketCap":18893422},{"date":"2025-06-27","current":-1.062987,"twenty":-0.903534,"median":-0.664004,"eighty":-0.385875,"marketCap":17407423},{"date":"2025-07-03","current":-1.109655,"twenty":-0.908549,"median":-0.665177,"eighty":-0.388132,"marketCap":18171651},{"date":"2025-07-11","current":-1.148544,"twenty":-0.913055,"median":-0.665401,"eighty":-0.389215,"marketCap":18808508},{"date":"2025-07-18","current":-1.247065,"twenty":-0.915869,"median":-0.668,"eighty":-0.394838,"marketCap":20421879},{"date":"2025-07-25","current":-1.392254,"twenty":-0.919559,"median":-0.668858,"eighty":-0.403737,"marketCap":22799478},{"date":"2025-08-01","current":-1.381086,"twenty":-0.922817,"median":-0.671821,"eighty":-0.411148,"marketCap":22616589},{"date":"2025-08-08","current":-1.353457,"twenty":-0.923657,"median":-0.672582,"eighty":-0.416869,"marketCap":22164142},{"date":"2025-08-15","current":-1.327738,"twenty":-0.927784,"median":-0.676051,"eighty":-0.421572,"marketCap":21742971},{"date":"2025-08-22","current":-1.202782,"twenty":-0.936843,"median":-0.677278,"eighty":-0.423841,"marketCap":21595966},{"date":"2025-08-29","current":-1.18771,"twenty":-0.946354,"median":-0.677278,"eighty":-0.426147,"marketCap":21325340},{"date":"2025-09-05","current":-1.142492,"twenty":-0.954133,"median":-0.679106,"eighty":-0.427428,"marketCap":20513462},{"date":"2025-09-12","current":-1.227052,"twenty":-0.95551,"median":-0.679593,"eighty":-0.429115,"marketCap":22031733},{"date":"2025-09-19","current":-1.099039,"twenty":-0.970024,"median":-0.681444,"eighty":-0.431865,"marketCap":19733257},{"date":"2025-09-26","current":-1.18334,"twenty":-0.976023,"median":-0.682691,"eighty":-0.432761,"marketCap":21246887},{"date":"2025-10-03","current":-1.267642,"twenty":-0.978497,"median":-0.683243,"eighty":-0.433712,"marketCap":22760518},{"date":"2025-10-10","current":-1.358188,"twenty":-0.98514,"median":-0.684243,"eighty":-0.434678,"marketCap":24386269},{"date":"2025-10-17","current":-1.186463,"twenty":-0.991929,"median":-0.686,"eighty":-0.437111,"marketCap":21302948},{"date":"2025-10-24","current":-1.117773,"twenty":-1.00098,"median":-0.686555,"eighty":-0.439432,"marketCap":20069619},{"date":"2025-10-31","current":-1.12714,"twenty":-1.00952,"median":-0.687198,"eighty":-0.44001,"marketCap":20237800},{"date":"2025-11-07","current":-1.148995,"twenty":-1.01206,"median":-0.687503,"eighty":-0.440681,"marketCap":20630223},{"date":"2025-11-14","current":-1.039716,"twenty":-1.015718,"median":-0.687963,"eighty":-0.44228,"marketCap":18668109},{"date":"2025-11-21","current":-1.092793,"twenty":-1.020921,"median":-0.690454,"eighty":-0.443582,"marketCap":23379462},{"date":"2025-11-28","current":-1.178068,"twenty":-1.029746,"median":-0.690966,"eighty":-0.444201,"marketCap":25203871},{"date":"2025-12-05","current":-1.244394,"twenty":-1.041858,"median":-0.69125,"eighty":-0.444201,"marketCap":26622855},{"date":"2025-12-12","current":-1.320195,"twenty":-1.047385,"median":-0.691479,"eighty":-0.44484,"marketCap":28244552},{"date":"2025-12-19","current":-1.219127,"twenty":-1.051634,"median":-0.691859,"eighty":-0.447462,"marketCap":26082290},{"date":"2025-12-26","current":-1.275978,"twenty":-1.055209,"median":-0.695635,"eighty":-0.447732,"marketCap":27298562},{"date":"2026-01-02","current":-1.370728,"twenty":-1.060077,"median":-0.696624,"eighty":-0.44826,"marketCap":29325683},{"date":"2026-01-09","current":-1.705802,"twenty":-1.070932,"median":-0.69751,"eighty":-0.448392,"marketCap":36494328},{"date":"2026-01-16","current":-1.826686,"twenty":-1.075265,"median":-0.697627,"eighty":-0.448392,"marketCap":39080541},{"date":"2026-01-23","current":-1.803181,"twenty":-1.087696,"median":-0.69795,"eighty":-0.448392,"marketCap":38577666},{"date":"2026-01-30","current":-1.920706,"twenty":-1.098033,"median":-0.699735,"eighty":-0.448392,"marketCap":41092039},{"date":"2026-02-06","current":-2.179263,"twenty":-1.102462,"median":-0.701223,"eighty":-0.448392,"marketCap":46623660},{"date":"2026-02-13","current":-2.193674,"twenty":-1.110842,"median":-0.701682,"eighty":-0.448721,"marketCap":46931965},{"date":"2026-02-20","current":-2.946201,"twenty":-1.114901,"median":-0.702789,"eighty":-0.449386,"marketCap":63031719},{"date":"2026-02-25","current":-3.087424,"twenty":-1.11626,"median":-0.704174,"eighty":-0.450055,"marketCap":66053074}],"updateTime":1772106101072},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CING\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584602889","title":"Cingulate price target lowered to $16 from $17 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2584602889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584602889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 08:55","pubTimestamp":1763513707,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Boobalan Pachaiyappan lowered the firm’s price target on Cingulate (CING) to $16 from $17 and keeps a Buy rating on the shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-lowered-to-16-from-17-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-lowered-to-16-from-17-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"gpt_icon":0},{"id":"2584796658","title":"Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2584796658","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584796658?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:28","pubTimestamp":1763501304,"startTime":"0","endTime":"0","summary":"Cingulate Inc. announced the execution of an exclusive commercial supply agreement with Bend Bio Sciences to secure U.S. manufacturing capacity for its lead product candidate, CTx-1301. This agreement is part of Cingulate's preparation for a potential 2026 launch of CTx-1301, pending FDA approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cingulate Inc. published the original content used to generate this news brief via Newsfile  on November 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL1Gv5qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2584644000","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644000","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644000?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:00","pubTimestamp":1763377200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·J & J Snack Fds                                 4Q      1.24        BMO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","WB","CRGO","BRBR","CING","CRNC","ANRO","DLB","NVDA","TCOM","CDLR","ARMK","TBBB","ZTO","BBWI","CLCO","BMA","VIPS","ACM","NTES","DY","CRDL","BZ","BV","AZTA","TGT","ALLT","AHL","EARN","CGON","ENTA","BNTC","AS","AREC","ARBE","ATKR","CPA","CPRT","DE","ENR","WMT","ATRA","ADIL","CLSD","POWL","BULL","XP"],"gpt_icon":1},{"id":"2583655005","title":"Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2583655005","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583655005?lang=en_us&edition=fundamental","pubTime":"2025-11-16 00:25","pubTimestamp":1763223929,"startTime":"0","endTime":"0","summary":"Cingulate Inc, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Naz Rahman from Maxim Group reiterated a Bu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cingulate-inc-s-promising-market-position-bolstered-by-strategic-partnerships-and-innovative-adhd-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cingulate-inc-s-promising-market-position-bolstered-by-strategic-partnerships-and-innovative-adhd-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","ADHD","CING","BK4588","XLV","BK4139","ABVC","BK4581","BK4007","XBI"],"gpt_icon":0},{"id":"2583980577","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2583980577","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583980577?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:00","pubTimestamp":1763118000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Li Auto Inc. Sp ADR                               3Q       .10. ·J & J Snack Fds                                 4Q      1.24        BMO","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTA","BBWI","CRGO","BMA","ADIL","ACM","DY","LGN","NTES","CPA","BZ","TGT","BTBT","BNTC","CLSD","CLCO","BBAR","WB","ANRO","CRNC","CRDL","AREC","BNZI","ATOS","CGON","ATKR","DLB","ARBE","DEFT","POWL","TCOM","ARMK","ATRA","AS","AHL","ATAI","DE","ZTO","NVDA","BV","ALLT","CDLR","CING","XP","BRBR"],"gpt_icon":1},{"id":"2583598435","title":"Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598435","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583598435?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:16","pubTimestamp":1763039801,"startTime":"0","endTime":"0","summary":"As of September 30, 2025, Cingulate (CING) had approximately $6.1 million in cash and cash equivalents, a $6.1 million decrease from December 31, 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-reports-q3-net-loss-7-3m-vs-4-1m-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-reports-q3-net-loss-7-3m-vs-4-1m-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2583598619","title":"Biopharma firm Cingulate's Q3 net loss widens, misses analyst expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598619","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583598619?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:09","pubTimestamp":1763039394,"startTime":"0","endTime":"0","summary":"Biopharma firm Cingulate's Q3 net loss widens, misses analyst expectationsOverviewCingulate Q3 net loss of $7.3 mln missed analyst expectationsR&D expenses rose 99.5% due to NDA submission costs for C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP0JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2583560206","title":"Cingulate Inc. posts third quarter loss of $6.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560206?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:00","pubTimestamp":1763038826,"startTime":"0","endTime":"0","summary":"Cingulate Inc. reported a net loss of $6.0 million for the third quarter of 2025, compared to a net loss of $3.3 million in the same period in 2024. For the nine months ended September 30, 2025, the net loss was $14.4 million, up from $9.4 million in the prior year period. Research and development expenses for the quarter were $2.8 million, and general and administrative expenses were $3.1 million, both higher than the previous year. As of September 30, 2025, cash and cash equivalents totaled $6.1 million, with total assets at $10.5 million and stockholders' equity at $3.5 million. During the period, the FDA accepted Cingulate's New Drug Application for CTx-1301, with a Prescription Drug User Fee Act  date set for May 31, 2026. The company also completed a $6.6 million financing transaction through a non-convertible, unsecured promissory note.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL9J4DcZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","NDAQ","BK4007","LU2210149790.SGD","CING","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2582893413","title":"Cingulate Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Bryan Wade Downey","url":"https://stock-news.laohu8.com/highlight/detail?id=2582893413","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582893413?lang=en_us&edition=fundamental","pubTime":"2025-11-11 07:00","pubTimestamp":1762815648,"startTime":"0","endTime":"0","summary":"Cingulate Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Bryan Wade Downey as the beneficial owner, who serves as the Chief Commercial Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cingulate Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL64bYF8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2582879799","title":"Cingulate Inc. Appoints Bryan Downey as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879799","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879799?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:03","pubTimestamp":1762779826,"startTime":"0","endTime":"0","summary":"Cingulate Inc. announced the appointment of Bryan Downey as Chief Commercial Officer. This leadership change comes as the company prepares for the potential commercialization of its lead product, CTx-1301, pending FDA approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cingulate Inc. published the original content used to generate this news brief via GlobeNewswire  on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLbHzqLq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4007","CING","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585"],"gpt_icon":0},{"id":"2582879286","title":"Press Release: Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879286","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879286?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779600,"startTime":"0","endTime":"0","summary":"Appointment builds on recent FDA acceptance of New Drug Application for review and advances Cingulate's transition toward commercialization pending FDA approval. Company also strengthens its cash position by completing a $6 million financing. Cingulate also announced it has completed a $6 million financing transaction, further strengthening its balance sheet and extending its cash runway into the second quarter of 2026, as the company prepares for commercialization, subject to FDA approval.\"Cingulate is at a pivotal moment as we prepare to bring CTx-1301 to market,\" said Bryan Downey, Chief Commercial Officer. \"The potential to deliver rapid onset and entire active-day ADHD symptom control in one daily dose is a substantial differentiator from medications currently available. With our new drug application now accepted for review, we're working closely with our partners at Indegene to establish the commercial infrastructure, market access execution, and launch readiness that will positi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","ADHD","PSQ","CING","TQQQ","BK4139","BK4604","03160","BK4555","QID","USAW.SI","ABVC","NQmain","NVIW.SI","TSYW.SI","TM","BK4099","BK4007","QLD","BK4585","MNQmain","SQQQ","BK4588",".IXIC"],"gpt_icon":1},{"id":"2578951980","title":"BRIEF-Cingulate Presents Positive Phase 3 Results for CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2578951980","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578951980?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:22","pubTimestamp":1761654141,"startTime":"0","endTime":"0","summary":"BRIEF-Cingulate Presents Positive Phase 3 Results for CTx-1301Oct 28 (Reuters) - Cingulate Inc CING.O:CINGULATE PRESENTS POSITIVE PHASE 3 RESULTS FOR CTX-1301 DEMONSTRATING STATISTICALLY SIGNIFICANT E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nTUABXQ6SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CINGW","BK4007","CING"],"gpt_icon":0},{"id":"2578959073","title":"Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2578959073","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578959073?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:00","pubTimestamp":1761652800,"startTime":"0","endTime":"0","summary":"Once-daily formulation of dexmethylphenidate achieved primary endpoint (p < 0.001) with consistent symptom relief up to 12 hours post-doseKANSAS CITY, Kan., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Cingula","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175360/0/en/Cingulate-Presents-Positive-Phase-3-Results-for-CTx-1301-Demonstrating-Statistically-Significant-Efficacy-and-Entire-Active-Day-Symptom-Control.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING"],"gpt_icon":0},{"id":"2577531411","title":"Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2577531411","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577531411?lang=en_us&edition=fundamental","pubTime":"2025-10-24 04:45","pubTimestamp":1761252300,"startTime":"0","endTime":"0","summary":"Presentation by ADHD expert Dr. Ann Childress to highlight Phase 3 findings supporting the potential for true, entire active-day symptom controlKANSAS CITY, Kan., Oct.  23, 2025  (GLOBE NEWSWIRE) -- C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172521/0/en/Cingulate-s-Lead-ADHD-Candidate-CTx-1301-Selected-for-Podium-Presentation-at-AACAP-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007","BK4139","ABVC","ADHD"],"gpt_icon":0},{"id":"2575730710","title":"Cingulate Is Maintained at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2575730710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575730710?lang=en_us&edition=fundamental","pubTime":"2025-10-16 02:00","pubTimestamp":1760551200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CING/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 15, 2025 14:00 ET (18:00 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING"],"gpt_icon":0},{"id":"2575731107","title":"Strategic Advancements and Partnerships Propel Cingulate Inc. Towards Market Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2575731107","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575731107?lang=en_us&edition=fundamental","pubTime":"2025-10-15 23:35","pubTimestamp":1760542520,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Cingulate Inc yesterday and set a price target of $8.00. Naz Rahman has given his Buy rat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-partnerships-propel-cingulate-inc-towards-market-success-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-partnerships-propel-cingulate-inc-towards-market-success-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"gpt_icon":0},{"id":"2575022724","title":"Cingulate price target raised to $17 from $10 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2575022724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575022724?lang=en_us&edition=fundamental","pubTime":"2025-10-15 09:25","pubTimestamp":1760491508,"startTime":"0","endTime":"0","summary":"Roth Capital raised the firm’s price target on Cingulate (CING) to $17 from $10 and keeps a Buy rating on the shares. The FDA’s acceptance of Cingu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-raised-to-17-from-10-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-raised-to-17-from-10-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"gpt_icon":0},{"id":"2575488297","title":"FDA Accepts Cingulate’s New Drug Application for Ctx-1301 in Attention-Deficit/Hyperactivity Disorder (Adhd) and Sets a May 31, 2026  Pdufa Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2575488297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575488297?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:00","pubTimestamp":1760443205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUA91VW9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CINGW","CING"],"gpt_icon":0},{"id":"2575290547","title":"FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026  PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2575290547","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575290547?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:00","pubTimestamp":1760443200,"startTime":"0","endTime":"0","summary":"Once-daily Precision Timed Release (PTR) stimulant designed to deliver rapid onset of effect and entire active-day durationNDA accepted under the FDA’s 505(b)(2) regulatory pathway KANSAS CITY, Kan., ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166151/0/en/FDA-Accepts-Cingulate-s-New-Drug-Application-for-CTx-1301-in-Attention-Deficit-Hyperactivity-Disorder-ADHD-and-sets-a-May-31-2026-PDUFA-Date.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BHPRN162.USD","LU2237443622.USD","LU2237443978.SGD","LU2237443895.HKD","LU0170899867.USD","CMC","IE00BZ1G4Q59.USD","LU0971096721.USD","CING","LU2237443382.USD","LU0267386448.USD","LU0149725797.USD","LU1363072403.SGD","LU2237443465.HKD","LU2746668461.USD","LU0882574139.USD","LU2746668974.SGD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","ABVC","BK4006","IE00BFXG1179.USD","BK4139","ADHD","LU2237443549.SGD","BK4007"],"gpt_icon":0},{"id":"2570044094","title":"Cingulate Inc Approves Stock Issuance Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2570044094","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570044094?lang=en_us&edition=fundamental","pubTime":"2025-09-26 05:30","pubTimestamp":1758835832,"startTime":"0","endTime":"0","summary":"Cingulate Inc ( ($CING) ) has shared an update. On September 25, 2025, Cingulate Inc. held a Special Meeting of Stockholders where two proposals we...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-approves-stock-issuance-proposal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-approves-stock-issuance-proposal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}]}}